Master of Biopharmaceutical Engineering (MBiopharmaE)
Master of Biopharmaceutical Engineering (MBiopharmaE)
Program Code
MBE
Program Faculty
Faculty of Sciences, Engineering and Technology
Academic Year
2021
These Program Rules should be read in conjunction with the University's policies (https://www.adelaide.edu.au/policies).
Overview
The program will provide considerable insight to the engineering, technical, management and regulatory issues associated with the biopharmaceutical industry. The main aim of this program is to provide an internationally recognised high-quality flexible curriculum. The Master of Biopharmaceutical Engineering will incorporate state-of-the-art developments in science, engineering and technology. The program meets the needs for Science and Engineering graduates requiring qualifications that are relevant to the global biopharmaceutical industry.
The Master of Biopharmaceutical Engineering is an AQF Level 9 qualification with a standard full-time duration of 2 years.
Conditions
Interruption of program: Students must apply for permission from the Faculty before taking a Leave of Absence. Any extension of the leave without approval will result in the loss of place in the program but an application may be made to be re-admitted to the program subject to the admission procedures in place at the time.
Academic Program Rules for Master of Biopharmaceutical Engineering
There shall be a Master of Biopharmaceutical Engineering.
Qualification Requirements
To qualify for the degree of Master of Biopharmaceutical Engineering, the student must complete satisfactorily a program of study consisting of the following requirements with a combined total of not less than 48 units, comprising:
Core courses to the value of 18 units
Elective courses to the value of 12 units
Research project to the value of 18 units
Entry Requirements
Applicants who already hold a 4-year Bachelor of Engineering (BE(Hons) degree or equivalent) are eligible to enrol in this MBiopharmaE program.
Applicants holding a Bachelor of Science (BSc(Hons)) degree (or equivalent) or a Bachelor of Engineering (BE(Hons) degree or equivalent) in a discipline other than chemical engineering are eligible to enrol in this MBiopharmaE program but must undertake CHEM ENG 7060 Principles of Biopharmaceutical Engineering.
Core Courses
-
Core Courses
To satisfy the requirements for Core Courses students must complete courses to the value of 18 units.
All of the following courses must be completed:
Subject/Catalogue Course Title Unit Value CHEM ENG 7061 Quality by Design and Process Analytical Technology 3 CHEM ENG 7062 Downstream Bioprocessing 3 CHEM ENG 7063 Good Manufacturing Practice, Validation and Regulation 3 CHEM ENG 7064 Upstream Bioprocessing and Bioformulation 3 CHEM ENG 7065 Batch and Continuous Biomanufacturing 3 CHEM ENG 7066 Advanced Technologies in Biopharmaceutical Processing 3 -
Research Project
To satisfy the requirements for Research Project students must complete courses to the value of 18 units.
All of the following courses must be completed:
Subject/Catalogue Course Title Unit Value CHEM ENG 7070A Biopharmaceutical Engineering Research Project Part A 0 CHEM ENG 7070B Biopharmaceutical Engineering Research Project Part B 18
Electives
-
Electives
To satisfy the requirements for Electives students must complete courses to the value of 12 units.
Courses to the value of 12 units from the following:
Subject/Catalogue Course Title Unit Value CHEM ENG 7021 Special Studies in Chemical Engineering 3 CHEM ENG 7030 Process Modelling & Control 3 CHEM ENG 7060 Principles of Biopharmaceutical Engineering 3 CHEM ENG 7109 Advanced Engineering of Biomaterials 3 ELEC ENG 7164 Business Management Systems PG 3 MATHS 7025 Research Methods and Statistics 3 PROJMGNT 5021 Project Management Fundamentals 3